BDX Q2 2021 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena

BDXBecton, Dickinson and Company

$59B

Q2 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$4.9B+15.4% YoY

Gross Profit

$2.2B45.8% margin

Operating Income

$434M8.8% margin

Net Income

$299M6.1% margin

EPS (Diluted)

$0.94

QoQ Revenue Growth

-7.7%

Cash Flow

Operating Cash Flow

$1.2B

Free Cash Flow

$935M

Stock-Based Comp.

$55M

Balance Sheet

Total Assets

$54.9B

Total Liabilities

$30.1B

Stockholders' Equity

$24.8B

Cash & Equivalents

$3.7B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.9B	$4.3B	+15.4%
Gross Profit	$2.2B	$1.7B	+29.6%
Operating Income	$434M	$370M	+17.3%
Net Income	$299M	$183M	+63.4%

Revenue Segments

Medical

$2.3B47%

Life Sciences

$1.6B32%

Interventional

$1.0B21%

Geographic Segments

UNITED STATES

$2.5B50%

Non-US

$2.4B50%